Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centered, Assessor-blinded Clinical Performance Study to Evaluate the Sensitivity and Specificity of the cCeLL-Ex Vivo Device for Intraoperative Brain Tumor Diagnosis.

NCT06098248 is registered in ClinicalTrials.gov with VPIX Medical as lead sponsor.

NCT NCT06098248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06098248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centered, Assessor-blinded Clinical Performance Study to Evaluate the Sensitivity and Specificity of the cCeLL-Ex Vivo Device for Intraoperative Brain Tumor Diagnosis.
Lead sponsor
VPIX Medical
Phase
Not applicable
Overall status
Terminated
Start date
January 1, 2023
Completion date
November 27, 2024
Enrollment
285 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

benign brain tumor, malignant brain tumor